Jiangsu Bioperfectus Technologies Co.,Ltd. announced that the company recently received the medical instruments registration certificate (in vitro diagnostic reagents) issued by the National Medical Products Administration, with the product being the Dengue virus nucleic acid detection kit (Fluorescent PCR method), used for qualitative detection of Dengue virus nucleic acid in human serum samples.
硕世生物:取得登革病毒核酸检测试剂盒医疗器械注册证
Jiangsu Bioperfectus Technologies Co.,Ltd.: obtained the medical instruments registration certificate for Dengue virus nucleic acid detection kit.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.